| 1 |
2024 |
Zhenni Wei, Bingyu Li, Xuejun Wen, Vivianne Jakobsson, Peifei Liu, Xiaoyuan Chen, Jingjing Zhang. Engineered Antibodies as Cancer Radiotheranostics, Advanced Science. 2024; 11: 2402361.
https://doi.org/10.1002/advs.202402361 |
| 2 |
2024 |
Jutatip Panaampon, Prin Sungwan, Sawako Fujikawa, Somponnat Sampattavanich, Siwanon Jirawatnotai, Seiji Okada. Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanisms, International Immunopharmacology. 2024; 138: 112612112612.
https://doi.org/10.1016/j.intimp.2024.112612 |
| 3 |
2025 |
Naveen Kumar, Shishu Kant Suman, Mohini Guleria, Soumi Kolay, Jeyachitra Amirdhanayagam, Avik Chakraborty, Sutapa Rakshit, Archana Mukherjee, Tapas Das. Chlorambucil Conjugation Enhances the Potency of Rituximab: Synthesis and Evaluation of the Novel [177Lu]Lu-Labeled Rituximab-Chlorambucil Conjugate toward Therapy of Non-Hodgkin’s Lymphoma, Journal of Medicinal Chemistry. 2025; acs.jmedchem.4c01954.
https://doi.org/10.1021/acs.jmedchem.4c01954 |
| 4 |
2024 |
Hiroki Goto, Yoshioki Shiraishi, Seiji Okada. Continuing progress in radioimmunotherapy for hematologic malignancies, Blood Reviews. 2024; 101250101250.
https://doi.org/10.1016/j.blre.2024.101250 |
| 5 |
2024 |
Pablo Cabral, Ximena Camacho. 2024;
https://doi.org/10.1007/7355_2024_169 |
| 6 |
2024 |
Xu Yang, Jun Liu, Cuicui Li, Lingling Zheng, Xia Lu, Ziang Zhou, Xianyu Zhu, Jianhua Gong, Qingfang Miao, Jigang Yang. Preclinical evaluation of 64Cu/177Lu-labelled anti-CD30 monoclonal antibody for theranostics in CD30-positive lymphoma, European Journal of Nuclear Medicine and Molecular Imaging. 2024;
https://doi.org/10.1007/s00259-024-07022-z |
| 7 |
2024 |
Pavithra Bharathy, Elizabeth Rani E, Punniyakoti V. Thanikachalam. Revolution of blood cancer treatment in the oral cavity: Breakthroughs in nanotherapy, Oral Oncology Reports. 2024; 11: 100635100635.
https://doi.org/10.1016/j.oor.2024.100635 |
